{"id":"https://openalex.org/W2997325374","doi":"https://doi.org/10.1093/glycob/cwz109","title":"Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA","display_name":"Characterization of disease-specific chondroitin sulfate nonreducing end accumulation in mucopolysaccharidosis IVA","publication_year":2020,"publication_date":"2020-01-02","ids":{"openalex":"https://openalex.org/W2997325374","doi":"https://doi.org/10.1093/glycob/cwz109","mag":"2997325374","pmid":"https://pubmed.ncbi.nlm.nih.gov/31897472"},"language":"en","primary_location":{"id":"doi:10.1093/glycob/cwz109","doi":"https://doi.org/10.1093/glycob/cwz109","is_oa":false,"landing_page_url":"https://doi.org/10.1093/glycob/cwz109","pdf_url":null,"source":{"id":"https://openalex.org/S188363740","display_name":"Glycobiology","issn_l":"0959-6658","issn":["0959-6658","1460-2423"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glycobiology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044915332","display_name":"Roger Lawrence","orcid":"https://orcid.org/0000-0002-5027-2579","observed_orcids":["https://orcid.org/0000-0002-5027-2579"]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Roger Lawrence","raw_affiliation_strings":["Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080740626","display_name":"Heather Prill","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Heather Prill","raw_affiliation_strings":["Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016525527","display_name":"Preejith P. Vachali","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4391767985","display_name":"ARUP Institute for Clinical and Experimental Pathology","ror":"https://ror.org/01zmyz259","country_code":"US","type":"facility","lineage":["https://openalex.org/I4391767985"]},{"id":"https://openalex.org/I61474668","display_name":"ARUP Laboratories (United States)","ror":"https://ror.org/00c2tyx86","country_code":"US","type":"company","lineage":["https://openalex.org/I61474668"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Preejith P Vachali","raw_affiliation_strings":["ARUP Institute for Clinical and Experimental Pathology\u00ae, 500 Chipeta Way, Salt Lake City, UT 84108, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARUP Institute for Clinical and Experimental Pathology\u00ae, 500 Chipeta Way, Salt Lake City, UT 84108, USA","institution_ids":["https://openalex.org/I4391767985","https://openalex.org/I61474668"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5025255235","display_name":"Evan G. Adintori","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Evan G Adintori","raw_affiliation_strings":["Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038774794","display_name":"Greg de Hart","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Greg de Hart","raw_affiliation_strings":["Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA","institution_ids":["https://openalex.org/I91786662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028989065","display_name":"Raymond Wang","orcid":"https://orcid.org/0000-0001-6494-7613","observed_orcids":["https://orcid.org/0000-0001-6494-7613"]},"institutions":[{"id":"https://openalex.org/I1304278710","display_name":"Children's Hospital of Orange County","ror":"https://ror.org/0282qcz50","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1304278710"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Raymond Y Wang","raw_affiliation_strings":["Division of Metabolic Disorders, Children's Hospital of Orange County, 1201 W. La Veta Ave., Orange, CA 92868, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Metabolic Disorders, Children's Hospital of Orange County, 1201 W. La Veta Ave., Orange, CA 92868, USA","institution_ids":["https://openalex.org/I1304278710"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109198306","display_name":"Barbara K. Burton","orcid":"https://orcid.org/0000-0002-3691-7190","observed_orcids":["https://orcid.org/0000-0002-3691-7190"]},"institutions":[{"id":"https://openalex.org/I1294278766","display_name":"Lurie Children's Hospital","ror":"https://ror.org/03a6zw892","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1294278766"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Barbara K Burton","raw_affiliation_strings":["Ann & Robert Lurie Children's Hospital, 225 E. Chicago Ave., Chicago, IL 60611, USA, and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ann & Robert Lurie Children's Hospital, 225 E. Chicago Ave., Chicago, IL 60611, USA, and","institution_ids":["https://openalex.org/I1294278766"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103246408","display_name":"Marzia Pasquali","orcid":"https://orcid.org/0000-0003-4217-4546","observed_orcids":["https://orcid.org/0000-0003-4217-4546"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I4391767985","display_name":"ARUP Institute for Clinical and Experimental Pathology","ror":"https://ror.org/01zmyz259","country_code":"US","type":"facility","lineage":["https://openalex.org/I4391767985"]},{"id":"https://openalex.org/I61474668","display_name":"ARUP Laboratories (United States)","ror":"https://ror.org/00c2tyx86","country_code":"US","type":"company","lineage":["https://openalex.org/I61474668"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marzia Pasquali","raw_affiliation_strings":["ARUP Institute for Clinical and Experimental Pathology\u00ae, 500 Chipeta Way, Salt Lake City, UT 84108, USA","University of Utah and ARUP Laboratories, Salt Lake City, UT 84108, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"ARUP Institute for Clinical and Experimental Pathology\u00ae, 500 Chipeta Way, Salt Lake City, UT 84108, USA","institution_ids":["https://openalex.org/I4391767985","https://openalex.org/I61474668"]},{"raw_affiliation_string":"University of Utah and ARUP Laboratories, Salt Lake City, UT 84108, USA","institution_ids":["https://openalex.org/I223532165","https://openalex.org/I61474668"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5036894367","display_name":"Brett E. Crawford","orcid":"https://orcid.org/0000-0002-7811-4564","observed_orcids":["https://orcid.org/0000-0002-7811-4564"]},"institutions":[{"id":"https://openalex.org/I91786662","display_name":"BioMarin (United States)","ror":"https://ror.org/03fmvqd28","country_code":"US","type":"company","lineage":["https://openalex.org/I91786662"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Brett E Crawford","raw_affiliation_strings":["Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Research, BioMarin Pharmaceutical Inc., 105 Digital Drive, Novato, CA 94949, USA","institution_ids":["https://openalex.org/I91786662"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":6,"corresponding_author_ids":["https://openalex.org/A5044915332"],"corresponding_institution_ids":["https://openalex.org/I91786662"],"apc_list":{"value":4208,"currency":"EUR","value_usd":4756},"apc_paid":null,"fwci":0.7506,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.68231565,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":89,"max":98},"biblio":{"volume":"30","issue":"7","first_page":"433","last_page":"445"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/morquio-syndrome-type-a","display_name":"Morquio syndrome type A","score":0.9120000004768372},{"id":"https://openalex.org/keywords/mucopolysaccharidosis-iva","display_name":"mucopolysaccharidosis IVA","score":0.9259999990463257},{"id":"https://openalex.org/keywords/chondroitin-sulfate","display_name":"chondroitin sulfate","score":0.972000002861023},{"id":"https://openalex.org/keywords/keratan-sulfate","display_name":"keratan sulfate","score":0.9509999752044678},{"id":"https://openalex.org/keywords/enzymatic-depolymerization","display_name":"enzymatic depolymerization","score":0.8090000152587891},{"id":"https://openalex.org/keywords/disease-diagnosis","display_name":"disease diagnosis","score":0.6579999923706055},{"id":"https://openalex.org/keywords/enzyme-replacement-therapy","display_name":"enzyme replacement therapy","score":0.8610000014305115},{"id":"https://openalex.org/keywords/pharmacodynamic-monitoring","display_name":"pharmacodynamic monitoring","score":0.8339999914169312},{"id":"https://openalex.org/keywords/lysosomal-storage-disorders","display_name":"lysosomal storage disease","score":0.6949999928474426}],"concepts":[{"id":"https://openalex.org/C2778230131","wikidata":"https://www.wikidata.org/wiki/Q2457767","display_name":"Keratan sulfate","level":4,"score":0.7346498966217041},{"id":"https://openalex.org/C2779553658","wikidata":"https://www.wikidata.org/wiki/Q408014","display_name":"Chondroitin sulfate","level":3,"score":0.7148578763008118},{"id":"https://openalex.org/C2781467277","wikidata":"https://www.wikidata.org/wiki/Q375145","display_name":"Galactosamine","level":3,"score":0.6992543935775757},{"id":"https://openalex.org/C2780871851","wikidata":"https://www.wikidata.org/wiki/Q7636184","display_name":"Sulfatase","level":3,"score":0.6495766639709473},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.5522947311401367},{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.5490052700042725},{"id":"https://openalex.org/C2779416428","wikidata":"https://www.wikidata.org/wiki/Q1479681","display_name":"Mucopolysaccharidosis","level":2,"score":0.5177901983261108},{"id":"https://openalex.org/C153074725","wikidata":"https://www.wikidata.org/wiki/Q407553","display_name":"Glycosaminoglycan","level":2,"score":0.4923011064529419},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.47289907932281494},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.4691055417060852},{"id":"https://openalex.org/C2779969927","wikidata":"https://www.wikidata.org/wiki/Q916766","display_name":"Enzyme replacement therapy","level":3,"score":0.43923497200012207},{"id":"https://openalex.org/C181199279","wikidata":"https://www.wikidata.org/wiki/Q8047","display_name":"Enzyme","level":2,"score":0.38556647300720215},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.27671611309051514},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.24453631043434143},{"id":"https://openalex.org/C2778125326","wikidata":"https://www.wikidata.org/wiki/Q327506","display_name":"Glucosamine","level":2,"score":0.2097969353199005}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002478","descriptor_name":"Cells, Cultured","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002809","descriptor_name":"Chondroitin Sulfates","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D002809","descriptor_name":"Chondroitin Sulfates","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D002809","descriptor_name":"Chondroitin Sulfates","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D002811","descriptor_name":"Chondroitinsulfatases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009085","descriptor_name":"Mucopolysaccharidosis IV","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009085","descriptor_name":"Mucopolysaccharidosis IV","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D009085","descriptor_name":"Mucopolysaccharidosis IV","qualifier_ui":"Q000652","qualifier_name":"urine","is_major_topic":false},{"descriptor_ui":"D056947","descriptor_name":"Enzyme Replacement Therapy","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/glycob/cwz109","doi":"https://doi.org/10.1093/glycob/cwz109","is_oa":false,"landing_page_url":"https://doi.org/10.1093/glycob/cwz109","pdf_url":null,"source":{"id":"https://openalex.org/S188363740","display_name":"Glycobiology","issn_l":"0959-6658","issn":["0959-6658","1460-2423"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glycobiology","raw_type":"journal-article"},{"id":"pmid:31897472","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/31897472","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Glycobiology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8371999859809875}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":40,"referenced_works":["https://openalex.org/W76220899","https://openalex.org/W1181099116","https://openalex.org/W1425646206","https://openalex.org/W1820870565","https://openalex.org/W1868648033","https://openalex.org/W1930879781","https://openalex.org/W1932105136","https://openalex.org/W1967296273","https://openalex.org/W1968496156","https://openalex.org/W1973443398","https://openalex.org/W1989186343","https://openalex.org/W2002659444","https://openalex.org/W2009162978","https://openalex.org/W2026388009","https://openalex.org/W2036429225","https://openalex.org/W2038117878","https://openalex.org/W2043490832","https://openalex.org/W2049452651","https://openalex.org/W2050474178","https://openalex.org/W2050598200","https://openalex.org/W2063346187","https://openalex.org/W2074268417","https://openalex.org/W2075022977","https://openalex.org/W2088174647","https://openalex.org/W2092849832","https://openalex.org/W2107730996","https://openalex.org/W2120105120","https://openalex.org/W2123558262","https://openalex.org/W2124552160","https://openalex.org/W2126183836","https://openalex.org/W2134220455","https://openalex.org/W2144058774","https://openalex.org/W2526629344","https://openalex.org/W2532004302","https://openalex.org/W2556384452","https://openalex.org/W2784146930","https://openalex.org/W2804407043","https://openalex.org/W2884257886","https://openalex.org/W2918819576","https://openalex.org/W4301208235"],"related_works":["https://openalex.org/W3040536110","https://openalex.org/W2803183799","https://openalex.org/W1992468001","https://openalex.org/W2134220455","https://openalex.org/W7098246280","https://openalex.org/W1964025230","https://openalex.org/W2597618249","https://openalex.org/W2034771716","https://openalex.org/W3007101482","https://openalex.org/W1979655719"],"abstract_inverted_index":{"Morquio":[0],"syndrome":[1],"type":[2],"A,":[3],"also":[4],"known":[5],"as":[6],"MPS":[7,40,78,98,135,181],"IVA,":[8],"is":[9,75],"a":[10,20,44,130],"rare":[11],"autosomal":[12],"recessive":[13],"disorder":[14],"caused":[15],"by":[16,124],"deficiency":[17],"of":[18,27,61,67,90,109,134,141,161,173],"N-acetylgalactosamine-6-sulfatase,":[19],"lysosomal":[21],"hydrolase":[22],"critical":[23],"in":[24,39,102,180],"the":[25,86,119,142,158,170],"degradation":[26],"keratan":[28],"sulfate":[29,33],"(KS)":[30],"and":[31,88,93,111,154],"chondroitin":[32],"(CS).":[34],"The":[35,65],"CS":[36,62],"that":[37],"accumulates":[38],"IVA":[41,99,182],"patients":[42],"has":[43],"disease-specific":[45],"nonreducing":[46],"end":[47],"(NRE)":[48],"terminating":[49],"with":[50,113],"N-acetyl-D-galactosamine":[51,68,91],"6-sulfate,":[52],"which":[53,128],"can":[54],"be":[55,166],"specifically":[56],"quantified":[57],"after":[58],"enzymatic":[59],"depolymerization":[60],"polysaccharide":[63],"chains.":[64],"abundance":[66],"6-sulfate":[69,92],"over":[70],"other":[71],"possible":[72],"NRE":[73],"structures":[74],"diagnostic":[76],"for":[77,85],"IVA.":[79,136],"Here,":[80],"we":[81],"describe":[82],"an":[83],"assay":[84,117,123],"liberation":[87],"measurement":[89],"explore":[94],"its":[95],"application":[96],"to":[97,146,168,177],"patient":[100],"samples":[101],"pilot":[103],"studies":[104,164],"examining":[105],"disease":[106,143,150,179],"detection,":[107],"effects":[108],"age":[110,152],"treatment":[112],"enzyme-replacement":[114],"therapy.":[115],"This":[116],"complements":[118],"existing":[120],"urinary":[121],"KS":[122],"quantifying":[125],"CS-derived":[126,175],"substrates,":[127],"represent":[129],"distinct":[131],"biochemical":[132],"aspect":[133],"A":[137],"more":[138,147,155],"complete":[139],"understanding":[140],"could":[144],"help":[145],"definitively":[148],"detect":[149],"across":[151],"ranges":[153],"completely":[156],"measure":[157],"pharmacodynamic":[159],"efficacy":[160],"therapies.":[162],"Larger":[163],"will":[165],"needed":[167],"clarify":[169],"potential":[171],"value":[172],"this":[174],"substrate":[176],"manage":[178],"patients.":[183]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2020,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2020-01-10T00:00:00"}